Characterizing Disease Severity Through Surgical Recurrence Rates in Idiopathic Subglottic Stenosis
Open Access
- 21 May 2025
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 135 (10) , 3766-3773
Abstract
Objective: There is currently not a marker of disease severity in idiopathic subglottic stenosis (iSGS). Our objective was to characterize iSGS patients' disease severity using endoscopic surgery rates.Methods: This was a two‐center retrospective analysis of iSGS patients with a minimum of 4 years of follow up following an initial endoscopic procedure (laser wedge excision (LWE) or endoscopic dilation (ED)). Disease severity was classified into Groups A–C, based on whether patients had fewer (Group A), the same number (Group B), or more surgeries (Group C) in years 3–5 compared to years 1 and 2. Disease severity proportions were compared across institutions using chi‐square analysis. Nonparametric testing compared clinical characteristics such as age, BMI, and GERD across severity groups.Results: There were 104 patients from institution 1 and 53 patients from institution 2 that were all female and predominantly Caucasian. Both institutions had clinically and statistically similar proportions of patients in Group A (64% vs. 62%), Group B (20% vs. 19%), and Group C (16% vs. 19%) disease (p > 0.05). No clinical characteristic (e.g., age, sex, race, BMI, GERD) was associated with disease severity.Conclusion: Across tertiary care institutions there is a consistent proportion of iSGS patients who either demonstrate nonrecurrent/decelerating (Group A), stable but persistent (Group B), or rapidly recurring disease (Group C). Two‐year surgery rates appear to be an important timepoint for providing expectations to patients on the likelihood of possessing severe disease.Level of Evidence: 4Keywords
This publication has 17 references indexed in Scilit:
- Age and Menopausal Status in Idiopathic Subglottic StenosisThe Laryngoscope, 2024
- Impact of Procedural Variation in Endoscopic Dilation for Idiopathic Subglottic StenosisThe Laryngoscope, 2024
- Association between Estrogen Exposure and Idiopathic Subglottic StenosisThe Laryngoscope, 2023
- Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5‐Year UpdateOtolaryngology–Head and Neck Surgery, 2023
- Impact of Serial Intralesional Steroid Injections on Idiopathic Subglottic StenosisThe Laryngoscope, 2022
- Impact of Adjuvant Medical Therapies on Surgical Outcomes in Idiopathic Subglottic StenosisThe Laryngoscope, 2021
- Endoscopic Wedge Excisions with CO2 Laser for Subglottic StenosisThe Laryngoscope, 2020
- Comparative Treatment Outcomes for Patients With Idiopathic Subglottic StenosisJAMA Otolaryngology–Head & Neck Surgery, 2020
- Evaluating the Association of Clinical Factors With Symptomatic Recurrence of Idiopathic Subglottic StenosisJAMA Otolaryngology–Head & Neck Surgery, 2019
- Idiopathic subglottic stenosis: An evolving therapeutic algorithmThe Laryngoscope, 2013